About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Boston | 459 Studies

Clinical Trials Prostate CancerBoston

Prostate Cancer Clinical Trials in Boston

Find 459 clinical trials for prostate cancer near Boston, Massachusetts. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Boston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 81-100 of 459 trials

TerminatedRovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid TumorsThe primary objective of this study is to assess the safety and tolerability of rovalpituzumab tesirine in subjects with specific delta-like protein 3-expressing advanced solid…NCT02709889·Gilbert, Arizona and 29 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

Active not recruitingA Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid TumorsThe purpose of this study is to characterize the safety and tolerability of ALTA2618 in adults with AKT1 E17K-mutant advanced solid tumors.NCT06533059·La Jolla, California and 30 others

CompletedOPTimizing Treatment Focused Genetic Testing IN CancerThis two-part randomized controlled trial aims to evaluate the impact of pre-test video education as compared to pre-test Chatbot education.NCT04066361·Boston, Massachusetts

RecruitingA Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate CancerThe main purpose of the study is to assess the safety and tolerability of AZD2284, AZD2287, and AZD2275.NCT06879041·Palo Alto, California and 15 others

CompletedEmbr Thermal Device for Hot Flash Management in Prostate CancerThis study is being conducted to evaluate if the Embr thermal device is useful for men who experience bothersome hot flashes as a result of prostate cancer treatment.NCT04892914·Boston, Massachusetts

Active not recruiting177LuPSMA in Renal Cell CarcinomaThis study aims to evaluate the efficacy and safety of 177Lu-PSMA-617 as a systemic therapy in patients with PSMA-positive advanced clear cell renal cell carcinoma (ccRCC).NCT06964958·Boston, Massachusetts and 1 other

Not yet recruitingEvaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With CancerThe objective of this study is to assess two novel positron emission tomography (PET) radiotracers, \[64Cu\]CM500 and \[68Ga\]CM500, for Positron Emission Tomography-Magnetic…NCT07781852·Boston, Massachusetts and 2 others

TerminatedNeo-DAB: Darolutamide and Abemaciclib in Prostate CancerThis research study is trying to determine the safety and efficacy of the combination of two oral drugs, abemaciclib and darolutamide, with androgen deprivation therapy (ADT) in…NCT05617885·Boston, Massachusetts

RecruitingSerial MRI Scans During Radiation TherapyThis is a phase 1 study to determine the feasibility and utility of using serial magnetic resonance imaging (MRI) to assess treatment response during and after radiation therapy…NCT04188535·Boston, Massachusetts and 1 other

RecruitingRecoverPC: Relugolix vs GnRH Agonist in Quality of LifeThis study is testing the way that approved androgen deprivation therapy treatments, Leuprolide and Relugolix, for prostate cancer affect quality of life, blood levels…NCT05765500·Boston, Massachusetts and 2 others

TerminatedSafety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GS-5829 (Alobresib) as a Single Agent and In Combination With Enzalutamide in Participants With Metastatic Castrate-Resistant Prostate CancerThis study consists of two phases: Dose Escalation (Phase 1b) and Dose Expansion (Phase 2) The Dose Escalation phase will characterize the safety, tolerability, and determine the…NCT02607228·San Francisco, California and 3 others

Active not recruitingContinued Access of Focal MR-Guided Focused Ultrasound for Localized Intermediate Risk Prostate LesionsThis extended clinical investigation is a multicenter, prospective, single arm study intended to provide continued access of the Exablate Model 2100 device (Exablate Prostate) to…NCT03998657·Stanford, California and 4 others

CompletedEpoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate CancerRATIONALE: Epoetin alfa may stimulate red blood cell production and may help improve cancer-related anemia and fatigue.NCT00060398·Modesto, California and 139 others

CompletedZoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone MetastasesRATIONALE: Zoledronate may prevent or decrease skeletal (bone)-related events (such as pain or fractures) caused by bone metastases and androgen deprivation therapy.NCT00079001·Mobile, Alabama and 240 others

CompletedCPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced CancersThis is a Phase 1/1b open-label, dose escalation and dose expansion study of CPI-006, a humanized monoclonal antibody (mAb) targeting the CD73 cell-surface ectonucleotidase in…NCT03454451·Tucson, Arizona and 26 others

TerminatedMuscadine Plus (MPX) In Men With Prostate CancerThis research is being done to determine if men with rising PSA after initial therapy for localized prostate cancer who display the Alanine/Alanine SOD2 genotype of MnSOD and…NCT03535675·Duarte, California and 12 others

CompletedA Study of Atezolizumab (Anti-PD-L1 Antibody) in Combination With Enzalutamide in Participants With Metastatic Castration-Resistant Prostrate Cancer (mCRPC) After Failure of an Androgen Synthesis Inhibitor And Failure of, Ineligibility For, or Refusal of a Taxane RegimenThis Phase III, multicenter, randomized, open-label study will evaluate the safety and efficacy of atezolizumab (anti-programmed death-ligand 1 \[anti-PD-L1\] antibody) in…NCT03016312·Duarte, California and 157 others

CompletedProstvac in Patients With Biochemically Recurrent Prostate CancerBackground: Some people who have been treated for prostate cancer still have high prostate-specific antigen (PSA) levels. This may indicate cancer.NCT02649439·Boston, Massachusetts and 2 others

Active not recruitingEnzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate CancerThe purpose of this study is to determine the effectiveness of enzalutamide, versus a conventional non-steroidal anti androgen (NSAA), when combined with a luteinizing hormone…NCT02446405·Boston, Massachusetts and 81 others

Active not recruitingAn International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Standard of Care (SoC), Versus SoC Alone, in Adult Male Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)The purpose of this study is to evaluate the efficacy and safety of 177Lu-PSMA-617 in combination with Standard of Care (SOC), versus Standard of Care alone, in adult male…NCT04720157·Scottsdale, Arizona and 163 others

PreviousPage 5 of 23Next

Other Conditions in Boston

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma